\-\ Texto\\:\\ \ \(0\)\
\-\ initial\\ labs\\:\ \(0\)\
\-\ hemoglobin\\ 10\\.3\\ m\\/ul\ \(0\)\
\-\ hematocrit\\ 29\\.2\\ \\%\ \(0\)\
\-\ normal\\ reticulocyte\\ counts\\,\\ iron\\,\\ tibc\\ and\\ iron\\ saturation\\.\ \(0\)\
\-\ labs\\ after\\ ct\\ of\\ the\\ abdomen\\ and\\ pelvis\\:\ \(0\)\
\-\ ca\\ 125\\:\\ \\ 1365\\ \\(0\\-34\\ u\\/ml\\)\ \(0\)\
\-\ patient\\ in\\ pending\\ evaluation\\ by\\ gynecology\\ oncology\\.\ \(0\)\
\-\ contrast\\ enhanced\\ axial\\ images\\ of\\ the\\ abdomen\\ and\\ pelvis\\ demonstrate\\ a\\ soft\\ tissue\\ density\\ in\\ lower\\ abdomen\\ between\\ the\\ abdominal\\ wall\\ and\\ small\\ bowel\\ consistent\\ with\\ an\\ omental\\ cake\\.\\ \\ \ \(0\)\
\-\ a\\ fluid\\ collection\\ in\\ the\\ pelvis\\ with\\ a\\ cystic\\ lesion\\ in\\ the\\ left\\ ovary\\ is\\ demonstrated\\.\ \(0\)\
\-\ ovarian\\ cancer\ \(16\)\
\-\ ovarian\\ cancer\\ with\\ peritoneal\\ carcinomatosis\ \(0\)\
\-\ metastatic\\ disease\\ from\\ occult\\ colon\\ or\\ stomach\\ cancer\ \(0\)\
\-\ 74\\ year\\ old\\ white\\ female\\ with\\ normocytic\\,\\ normochromic\\ anemia\\.\\ \\ evaluation\\ for\\ lymphoma\\.\ \(0\)\
\-\ the\\ ct\\ of\\ the\\ abdomen\\ and\\ pelvis\\ in\\ this\\ case\\ carried\\ the\\ provisional\\ diagnosis\\ of\\ lymphoma\\.\\ \\ the\\ patient\\'s\\ examination\\ did\\ not\\ demonstrate\\ evidence\\ of\\ lymphadenopathy\\.\\ \\ \ \(0\)\
\-\ omental\\ cake\\ represents\\ soft\\ tissue\\ attenuation\\ that\\ can\\ occur\\ within\\ the\\ peritoneum\\ from\\ metastatic\\ disease\\ from\\ ovarian\\,\\ gastric\\ or\\ colon\\ malignancy\\.\\ \\ with\\ the\\ constellation\\ of\\ peritoneal\\ fluid\\ and\\ a\\ cystic\\ appearance\\ to\\ the\\ left\\ ovary\\,\\ ovarian\\ cancer\\ was\\ the\\ most\\ likely\\ diagnosis\\.\\ \\ subsequent\\ ultrasound\\ of\\ the\\ abdomen\\ demonstrated\\ a\\ complex\\ fluid\\ collection\\ within\\ the\\ culdesac\\ but\\ no\\ identifiable\\ cysts\\ or\\ additional\\ information\\.\\ \\ \ \(0\)\
\-\ ca\\ 125\\ is\\ expressed\\ by\\ coelomic\\ epithelium\\ in\\ fetal\\ development\\ and\\ is\\ most\\ often\\ expressed\\ by\\ epithelial\\ ovarian\\ cancer\\.\\ \\ it\\ can\\,\\ however\\,\\ be\\ expressed\\ in\\ other\\ malignancies\\.\ \(0\)\
\-\ subsequently\\,\\ a\\ ca\\ 125\\ was\\ drawn\\ and\\ was\\ strongly\\ positive\\ and\\ suggestive\\ for\\ ovarian\\ cancer\\.\\ \\ this\\ tumor\\ marker\\ has\\ been\\ used\\ as\\ an\\ adjunct\\ in\\ postmenopausal\\ women\\ with\\ asymptomatic\\ pelvic\\ masses\\.\\ \\ levels\\ greater\\ than\\ 65\\ units\\ per\\ ml\\ have\\ a\\ positive\\ predictive\\ value\\ of\\ 98\\ percent\\ for\\ ovarian\\ cancer\\.\ \(0\)\
\-\ perkins\\,\\ g\\.\\,\\ slater\\,\\ e\\.\\,\\ sanders\\,\\ g\\.\\,\\ and\\ prichard\\,\\ j\\.\\ \\ \\"serum\\ tumor\\ markers\\.\\"\\ \\ american\\ family\\ physician\\.\\ volume\\ 68\\,\\ number\\ 6\\,\\ september\\ 15\\,\\ 2003\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ovarian\\:\\ 0\\.3448773288499529\ \(0\)\
\-\ cancer\\:\\ 0\\.26963126502546086\ \(0\)\
\-\ expressed\\:\\ 0\\.2284988526833042\ \(0\)\
\-\ 125\\:\\ 0\\.1921875327786445\ \(0\)\
\-\ abdomen\\:\\ 0\\.17642915118874372\ \(0\)\
\-\ the\\:\\ 0\\.1730871817015925\ \(0\)\
\-\ cake\\:\\ 0\\.1709109528813002\ \(0\)\
\-\ pelvis\\:\\ 0\\.16178612187423763\ \(0\)\
\-\ ca\\:\\ 0\\.14801950655423746\ \(0\)\
\-\ omental\\:\\ 0\\.134581876246709\ \(0\)\
\-\ iron\\:\\ 0\\.12751973380754403\ \(0\)\
\-\ and\\:\\ 0\\.11949825239950632\ \(0\)\
\-\ in\\:\\ 0\\.11508946830297863\ \(0\)\
\-\ ovary\\:\\ 0\\.11316972847137322\ \(0\)\
\-\ peritoneal\\:\\ 0\\.10870420464657657\ \(0\)\
\-\ ml\\:\\ 0\\.10465692148324658\ \(0\)\
\-\ fluid\\:\\ 0\\.10016900031118307\ \(0\)\
\-\ collection\\:\\ 0\\.09339327822933872\ \(0\)\
\-\ 1365\\:\\ 0\\.0924824790808153\ \(0\)\
\-\ culdesac\\:\\ 0\\.0924824790808153\ \(0\)\
\-\ coelomic\\:\\ 0\\.0924824790808153\ \(0\)\
\-\ perkins\\:\\ 0\\.0924824790808153\ \(0\)\
\-\ prichard\\:\\ 0\\.0924824790808153\ \(0\)\
\-\ of\\:\\ 0\\.09053632561474514\ \(0\)\
\-\ reticulocyte\\:\\ 0\\.08837194604385011\ \(0\)\
\-\ slater\\:\\ 0\\.08837194604385011\ \(0\)\
\-\ colon\\:\\ 0\\.08806515290918492\ \(0\)\
\-\ normochromic\\:\\ 0\\.0854554764406501\ \(0\)\
\-\ sanders\\:\\ 0\\.0854554764406501\ \(0\)\
\-\ tibc\\:\\ 0\\.08134494340368491\ \(0\)\
\-\ labs\\:\\ 0\\.08013006680503847\ \(0\)\
\-\ normocytic\\:\\ 0\\.07978219127180096\ \(0\)\
\-\ carried\\:\\ 0\\.07978219127180096\ \(0\)\
\-\ postmenopausal\\:\\ 0\\.07978219127180096\ \(0\)\
\-\ positive\\:\\ 0\\.07621376868524042\ \(0\)\
\-\ provisional\\:\\ 0\\.07616628422776806\ \(0\)\
\-\ gynecology\\:\\ 0\\.07520004660334524\ \(0\)\
\-\ by\\:\\ 0\\.07367369247806735\ \(0\)\
\-\ predictive\\:\\ 0\\.07350648205183088\ \(0\)\
\-\ adjunct\\:\\ 0\\.07275518863163576\ \(0\)\
\-\ counts\\:\\ 0\\.07205575119080285\ \(0\)\
\-\ demonstrated\\:\\ 0\\.07108130851417106\ \(0\)\
\-\ evaluation\\:\\ 0\\.07053574258528512\ \(0\)\
\-\ cystic\\:\\ 0\\.06965787197750584\ \(0\)\
\-\ from\\:\\ 0\\.06890266377083587\ \(0\)\
\-\ lymphoma\\:\\ 0\\.06888248271954689\ \(0\)\
\-\ peritoneum\\:\\ 0\\.06817304396318004\ \(0\)\
\-\ identifiable\\:\\ 0\\.06817304396318004\ \(0\)\
\-\ with\\:\\ 0\\.06794281578579475\ \(0\)\
\-\ september\\:\\ 0\\.0672909381233545\ \(0\)\
\-\ markers\\:\\ 0\\.06687709201488601\ \(0\)\
\-\ epithelium\\:\\ 0\\.06647947941166568\ \(0\)\
\-\ constellation\\:\\ 0\\.06572818599147055\ \(0\)\
\-\ marker\\:\\ 0\\.06572818599147055\ \(0\)\
\-\ malignancies\\:\\ 0\\.06502874855063764\ \(0\)\
\-\ metastatic\\:\\ 0\\.06343353177479552\ \(0\)\
\-\ drawn\\:\\ 0\\.0631804050863893\ \(0\)\
\-\ carcinomatosis\\:\\ 0\\.06263228122861683\ \(0\)\
\-\ occult\\:\\ 0\\.06211227894743765\ \(0\)\
\-\ epithelial\\:\\ 0\\.06211227894743765\ \(0\)\
\-\ oncology\\:\\ 0\\.06186194963970687\ \(0\)\
\-\ soft\\:\\ 0\\.061574735984626164\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.06114604132301484\ \(0\)\
\-\ units\\:\\ 0\\.06114604132301484\ \(0\)\
\-\ can\\:\\ 0\\.060694519744761595\ \(0\)\
\-\ tissue\\:\\ 0\\.0606724450079893\ \(0\)\
\-\ tumor\\:\\ 0\\.060496707017474415\ \(0\)\
\-\ was\\:\\ 0\\.06046279921682162\ \(0\)\
\-\ or\\:\\ 0\\.06035389868660201\ \(0\)\
\-\ most\\:\\ 0\\.06019278375510159\ \(0\)\
\-\ demonstrate\\:\\ 0\\.06012824584260913\ \(0\)\
\-\ saturation\\:\\ 0\\.060054900822621396\ \(0\)\
\-\ diagnosis\\:\\ 0\\.059957142348524096\ \(0\)\
\-\ hematocrit\\:\\ 0\\.059850089374720805\ \(0\)\
\-\ value\\:\\ 0\\.05888385175029799\ \(0\)\
\-\ strongly\\:\\ 0\\.05817213348196538\ \(0\)\
\-\ 74\\:\\ 0\\.057507119917540137\ \(0\)\
\-\ information\\:\\ 0\\.05719028719878362\ \(0\)\
\-\ percent\\:\\ 0\\.05719028719878362\ \(0\)\
\-\ 98\\:\\ 0\\.056013568203571215\ \(0\)\
\-\ 68\\:\\ 0\\.055605278588451636\ \(0\)\
\-\ fetal\\:\\ 0\\.05366839463248661\ \(0\)\
\-\ within\\:\\ 0\\.053269267866036356\ \(0\)\
\-\ number\\:\\ 0\\.0532369328430241\ \(0\)\
\-\ anemia\\:\\ 0\\.05313187675407134\ \(0\)\
\-\ for\\:\\ 0\\.05258332800755676\ \(0\)\
\-\ women\\:\\ 0\\.05204286940925889\ \(0\)\
\-\ 2003\\:\\ 0\\.05204286940925889\ \(0\)\
\-\ serum\\:\\ 0\\.05185684911013279\ \(0\)\
\-\ represents\\:\\ 0\\.05167418071114014\ \(0\)\
\-\ volume\\:\\ 0\\.050807172151634564\ \(0\)\
\-\ physician\\:\\ 0\\.05072441396257646\ \(0\)\
\-\ 65\\:\\ 0\\.04948466400777193\ \(0\)\
\-\ subsequently\\:\\ 0\\.04933983551807915\ \(0\)\
\-\ american\\:\\ 0\\.04933983551807915\ \(0\)\
\-\ gastric\\:\\ 0\\.048712553697590394\ \(0\)\
\-\ disease\\:\\ 0\\.048549811870292635\ \(0\)\
\-\ stomach\\:\\ 0\\.04825016245951518\ \(0\)\
\-\ per\\:\\ 0\\.04799510946363745\ \(0\)\
\-\ development\\:\\ 0\\.047807944359376464\ \(0\)\
\-\ pending\\:\\ 0\\.04756364767417494\ \(0\)\
\-\ is\\:\\ 0\\.04751127106620814\ \(0\)\
\-\ suggestive\\:\\ 0\\.047092036042684436\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.04675218896248611\ \(0\)\
\-\ levels\\:\\ 0\\.0458469003504697\ \(0\)\
\-\ family\\:\\ 0\\.04549642222283281\ \(0\)\
\-\ pelvic\\:\\ 0\\.04520536428377825\ \(0\)\
\-\ additional\\:\\ 0\\.044829846469967585\ \(0\)\
\-\ complex\\:\\ 0\\.044557063505524616\ \(0\)\
\-\ attenuation\\:\\ 0\\.04424782491974428\ \(0\)\
\-\ an\\:\\ 0\\.04422786159448777\ \(0\)\
\-\ ct\\:\\ 0\\.04403271433518053\ \(0\)\
\-\ enhanced\\:\\ 0\\.04403257645459246\ \(0\)\
\-\ cysts\\:\\ 0\\.04382180333532849\ \(0\)\
\-\ subsequent\\:\\ 0\\.04378016951146936\ \(0\)\
\-\ malignancy\\:\\ 0\\.0432934605996589\ \(0\)\
\-\ used\\:\\ 0\\.0432934605996589\ \(0\)\
\-\ greater\\:\\ 0\\.042604588893874376\ \(0\)\
\-\ occur\\:\\ 0\\.0425308589553562\ \(0\)\
\-\ did\\:\\ 0\\.0414847955495112\ \(0\)\
\-\ this\\:\\ 0\\.03974273830589084\ \(0\)\
\-\ left\\:\\ 0\\.039454028860722086\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.039369436773197056\ \(0\)\
\-\ masses\\:\\ 0\\.039369436773197056\ \(0\)\
\-\ 15\\:\\ 0\\.039077871473740936\ \(0\)\
\-\ initial\\:\\ 0\\.03879445774247207\ \(0\)\
\-\ density\\:\\ 0\\.03834712833064152\ \(0\)\
\-\ white\\:\\ 0\\.03815447983784271\ \(0\)\
\-\ often\\:\\ 0\\.03773395689298205\ \(0\)\
\-\ patient\\:\\ 0\\.037618277621063456\ \(0\)\
\-\ between\\:\\ 0\\.03757501802045999\ \(0\)\
\-\ bowel\\:\\ 0\\.03711262678238478\ \(0\)\
\-\ examination\\:\\ 0\\.037005573814427255\ \(0\)\
\-\ ultrasound\\:\\ 0\\.035670509194484286\ \(0\)\
\-\ wall\\:\\ 0\\.03517855069843917\ \(0\)\
\-\ appearance\\:\\ 0\\.03486335986516058\ \(0\)\
\-\ likely\\:\\ 0\\.03455767373560978\ \(0\)\
\-\ however\\:\\ 0\\.03422849475640052\ \(0\)\
\-\ been\\:\\ 0\\.03369231079283718\ \(0\)\
\-\ axial\\:\\ 0\\.033404586304891785\ \(0\)\
\-\ evidence\\:\\ 0\\.032824295048207205\ \(0\)\
\-\ than\\:\\ 0\\.03278208337641835\ \(0\)\
\-\ abdominal\\:\\ 0\\.031628665080890045\ \(0\)\
\-\ consistent\\:\\ 0\\.031356658421402735\ \(0\)\
\-\ other\\:\\ 0\\.030031956352188357\ \(0\)\
\-\ small\\:\\ 0\\.029830571146341845\ \(0\)\
\-\ it\\:\\ 0\\.029602278919301995\ \(0\)\
\-\ lower\\:\\ 0\\.029551103536218176\ \(0\)\
\-\ case\\:\\ 0\\.029053075018715825\ \(0\)\
\-\ have\\:\\ 0\\.028889169430730985\ \(0\)\
\-\ but\\:\\ 0\\.028596938618227975\ \(0\)\
\-\ contrast\\:\\ 0\\.028098331023413782\ \(0\)\
\-\ after\\:\\ 0\\.02805419589989105\ \(0\)\
\-\ female\\:\\ 0\\.027905557642910413\ \(0\)\
\-\ lesion\\:\\ 0\\.02772490436107304\ \(0\)\
\-\ images\\:\\ 0\\.02675014397712239\ \(0\)\
\-\ has\\:\\ 0\\.02641497884494119\ \(0\)\
\-\ that\\:\\ 0\\.025095975155992652\ \(0\)\
\-\ normal\\:\\ 0\\.02361152960808046\ \(0\)\
\-\ be\\:\\ 0\\.02345924791851877\ \(0\)\
\-\ as\\:\\ 0\\.02323229293316505\ \(0\)\
\-\ not\\:\\ 0\\.02282983911393591\ \(0\)\
\-\ no\\:\\ 0\\.018805600921170656\ \(0\)\
\-\ year\\:\\ 0\\.017822013361270178\ \(0\)\
\-\ old\\:\\ 0\\.01711530206984386\ \(0\)\
\-\ to\\:\\ 0\\.014457342547951158\ \(0\)\
